𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells

✍ Scribed by Anna E. Hills; Ashvin Patel; Paul Boyd; David C. James


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
246 KB
Volume
75
Category
Article
ISSN
0006-3592

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Functional proteomic analysis of GS-NS0
✍ Diane M. Dinnis; Scott H. Stansfield; Stefan Schlatter; C. Mark Smales; Daniel A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 2 views

We previously compared changes in individual protein abundance between the proteomes of GS-NS0 cell lines with varying rates of cell-specific recombinant monoclonal antibody production (qMab). Here we extend analyses of our proteomic dataset to statistically determine if particular cell lines have d

Fed-batch culture of recombinant NS0 mye
✍ Weichang Zhou; Chun-Chiang Chen; Barry Buckland; John Aunins 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 2 views

An amplified NS0 cell line transfected with a vector expressing a humanized monoclonal antibody (MAb) against CD-18 and glutamine synthetase (GS) was cultivated in a 1.5 L fed-batch culture using a serum-free, glutamine-free medium. Concentrated solutions of key nutrient components were fed periodic

Protein-free fed-batch culture of non-GS
✍ John E. Burky; Mark C. Wesson; Amy Young; Sharyn Farnsworth; Ben Dionne; Ying Zh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB 👁 2 views

## Abstract Presented is a novel antibody production platform based on the fed‐batch culture of recombinant, NS0‐derived cell lines. A standardized fed‐batch cell culture process was developed for five non‐GS NS0 cell lines using enriched and optimized protein‐free, cholesterol‐free, and chemically

Derivation and characterization of chole
✍ Taymar E. Hartman; Nalin Sar; Kimberly Genereux; Diana S. Barritt; Yimin He; Joh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB 👁 2 views

## Abstract Presented is an antibody production platform based on the fed‐batch culture of recombinant NS0‐derived cell lines. NS0 host cells, obtained from the European Collection of Cell Cultures (ECACC, Salisbury, UK, Part No. 85110503), were first adapted to grow in a protein‐free, cholesterol‐